Elixinol Wellness Limited
ELLXF
$0.01
$0.01248.78%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 34.86% | 53.81% | 80.06% | 69.50% | 54.85% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 35.05% | 53.92% | 80.06% | 69.50% | 54.85% |
| Cost of Revenue | 34.38% | 57.78% | 92.78% | 85.17% | 73.16% |
| Gross Profit | 36.29% | 47.31% | 60.63% | 46.61% | 29.42% |
| SG&A Expenses | 5.88% | 0.13% | -5.43% | -10.29% | -15.97% |
| Depreciation & Amortization | 15.18% | 39.10% | 73.58% | 66.50% | 56.22% |
| Other Operating Expenses | 961.39% | 304.03% | 198.87% | 141.48% | 84.65% |
| Total Operating Expenses | 23.84% | 31.05% | 39.46% | 28.42% | 15.56% |
| Operating Income | -0.39% | 8.09% | 15.87% | 19.95% | 24.52% |
| Income Before Tax | 18.86% | 24.50% | 29.64% | 15.96% | 2.24% |
| Income Tax Expenses | -197,800.00% | -148,356.25% | -118,690.00% | -70,794.12% | -14.29% |
| Earnings from Continuing Operations | 71.61% | 74.72% | 77.29% | 41.17% | 2.24% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 71.61% | 74.72% | 77.29% | 41.17% | 2.24% |
| EBIT | -0.39% | 8.09% | 15.87% | 19.95% | 24.52% |
| EBITDA | -0.01% | 13.35% | 24.82% | 26.39% | 28.77% |
| EPS Basic | 89.82% | 88.41% | 87.54% | 68.44% | 53.29% |
| Normalized Basic EPS | 51.61% | 61.67% | 67.26% | 65.32% | 64.62% |
| EPS Diluted | 89.86% | 88.44% | 87.57% | 68.37% | 53.11% |
| Normalized Diluted EPS | 51.61% | 61.67% | 67.26% | 65.32% | 64.62% |
| Average Basic Shares Outstanding | 105.12% | 126.00% | 160.95% | 149.93% | 134.49% |
| Average Diluted Shares Outstanding | 105.12% | 126.00% | 160.95% | 149.93% | 134.49% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |